SBIR Phase I: Empowering Discovery of COVID-19 Vaccine through Large Scale Unsupervised De — NSF Award to RocketML Inc (OR, $256,0
The broader impact of this Small Business Innovation Research (SBIR) Phase I project will be to empower researchers to make bio-structure discoveries by eliminating computational bottlenecks to shorten drug discovery cycles and time-to-market, such as those needed during the COVID-19 pandemic. Most modern drug discover
| Award title | SBIR Phase I: Empowering Discovery of COVID-19 Vaccine through Large Scale Unsupervised De |
|---|---|
| Award ID | 2032548 |
| Awardee | RocketML Inc |
| City | LAKE OSWEGO |
| State | OR |
| Amount obligated | $256,000 |
| Principal investigator | Vinay Rao |
| Program | SBIR Phase I |
| Start date | 09/01/2020 |
| Abstract | The broader impact of this Small Business Innovation Research (SBIR) Phase I project will be to empower researchers to make bio-structure discoveries by eliminating computational bottlenecks to shorten drug discovery cycles and time-to-market, such as those needed during the COVID-19 pandemic. Most modern drug discovery projects start with protein target identification and verification to obtain a 'verified drug target'. Structural vaccinology is a rational approach to generate an effective vacc |
| Source | NSF Awards |
$799/mo
Try NSFGrants →